IL1B and hyperlipidemia: In patients with periodontitis and hyperlipidemia, intensive periodontal treatment reduced the serum triglyceride and proinflammatory cytokine levels, that is, tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β (IL-1β), and IL-6 [24].